Mohammad Salavatizadeh

Mohammad Salavatizadeh

Auto-generated profile, based on publicly available information

Mohammad Salavatizadeh

Department of Pediatric Diseases, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 July 2025 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
MEMaryam Ehsasatvatan
Maryam Ehsasatvatan
BKBahram Baghban Kohnehrouz
Bahram Baghban Kohnehrouz
MSMohammad Salavatizadeh
Mohammad Salavatizadeh
Human metapneumovirus (hMPV) is a significant etiological agent of acute respiratory infections in children and immunocompromised individuals. Despite its growing clinical impact, no approved vaccines or targeted antiviral therapies are currently available. An immunoinformatic approach was employed to design a chimeric multi-epitope vaccine candidate against hMPV. Conserved and virulence-associated proteins were analyzed to predict highly antigenic B cell, cytotoxic T lymphocyte (CTL), and helper T lymphocyte (HTL) epitopes. The selected epitopes were screened for antigenicity, non-toxicity, non-allergenicity, and lack of homology to human proteins. The final construct included six B cell epitopes, six CTL epitopes, and two HTL epitopes, linked with appropriate adjuvants and Toll-like receptor (TLR) agonists. Structural modeling, molecular docking, and molecular dynamics simulations were conducted to evaluate the stability and receptor binding. Immunogenicity and expression potential were assessed through in silico immune simulation and codon optimization for expression in Escherichia coli. All selected epitopes showed high antigenicity with no allergenic or toxicity. Structural validation indicated a stable vaccine construct with favorable physicochemical properties. Molecular docking analysis predicted a high binding affinity between the vaccine construct and TLR2/TLR4 receptors. Molecular dynamics (MD) simulations suggested that the docked complexes maintained stable interactions under simulated physiological conditions. In silico immune simulations predicted strong B- and T-cell responses following three doses. Codon adaptation analysis supported the high-level expression in E. coli. The proposed multi-epitope vaccine demonstrates strong potential against hMPV, as supported by comprehensive computational analyses. Further experimental studies are required to validate its efficacy and safety.

1 June 2024 in Plant Biotechnology Persa
Verified
Journal Article
Open access
PDF file
MZMohammad Salavaty Zadeh
Mohammad Salavaty Zadeh
SMSudip Kumar Mandal
Sudip Kumar Mandal
Objective: Ear pain (earache) in children and infants often occurs when the ear canal becomes blocked, preventing fluid from draining. This blockage can lead to ear infections, causing pressure on the eardrum and resulting in pain. Other factors contributing to ear pain include infections, inflammation, fluid buildup, injury, and various ...